Search - tctmd.com

Displaying 41 - 60 of 356

Sort: Relevancy | Date

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

September 04, 2024

TCTMD’s Top 10 Most Popular Stories for August 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

September 03, 2024

What’s Going to Be Hot at ESC 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

August 23, 2024

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

News Daily News

‘Hey, ChatGPT: Surgery or the Cath Lab?’ Study Shows AI Can Aid Decision-Making

Yael L. Maxwell

August 14, 2024

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 09, 2024

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

June 21, 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

June 13, 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis

News Daily News

Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis

Yael L. Maxwell

May 28, 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

TCTMD’s Top 10 Most Popular Stories for February 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

March 01, 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.